Article
Pfizer Inc. announces that the FDA has approved new labeling claims forits Tecnis IOL. The approval marks the first time a lens has received suchclaims for reduction of postoperative spherical abberations and improvednight-driving simulator performance, the company said in a prepared statement.
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.